KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomarin Pharmaceutical (BMRN) Change in Acquisitions & Divestments (2016 - 2026)

Biomarin Pharmaceutical's Change in Acquisitions & Divestments history spans 17 years, with the latest figure at $43.3 million for Q4 2025.

  • For the quarter ending Q4 2025, Change in Acquisitions & Divestments fell 72.02% year-over-year to $43.3 million, compared with a TTM value of $337.8 million through Dec 2025, down 46.64%, and an annual FY2025 reading of $337.8 million, down 46.64% over the prior year.
  • Change in Acquisitions & Divestments for Q4 2025 was $43.3 million at Biomarin Pharmaceutical, down from $98.8 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $275.9 million in Q2 2023, with the low at $43.3 million in Q4 2025.
  • Average Change in Acquisitions & Divestments over 5 years is $157.3 million, with a median of $155.2 million recorded in 2022.
  • Year-over-year, Change in Acquisitions & Divestments surged 105.53% in 2021 and then plummeted 72.02% in 2025.
  • Tracing BMRN's Change in Acquisitions & Divestments over 5 years: stood at $188.9 million in 2021, then dropped by 24.45% to $142.8 million in 2022, then dropped by 20.71% to $113.2 million in 2023, then skyrocketed by 36.57% to $154.6 million in 2024, then plummeted by 72.02% to $43.3 million in 2025.
  • Per Business Quant, the three most recent readings for BMRN's Change in Acquisitions & Divestments are $43.3 million (Q4 2025), $98.8 million (Q3 2025), and $117.9 million (Q2 2025).